Roberto Vargas to Neoplasm Recurrence, Local
This is a "connection" page, showing publications Roberto Vargas has written about Neoplasm Recurrence, Local.
Connection Strength
1.608
-
Chambers LM, Michener CM, Rose PG, Reizes O, Yao M, Vargas R. Impact of antibiotic treatment on immunotherapy response in women with recurrent gynecologic cancer. Gynecol Oncol. 2021 04; 161(1):211-220.
Score: 0.632
-
Chambers LM, Kuznicki M, Yao M, Chichura A, Gruner M, Reizes O, Debernardo R, Rose PG, Michener C, Vargas R. Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer. Gynecol Oncol. 2020 12; 159(3):699-705.
Score: 0.617
-
Chambers LM, Chalif J, Yao M, Chichura A, Morton M, Gruner M, Costales AB, Horowitz M, Chau DB, Vargas R, Rose PG, Michener CM, Debernardo R. Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Gynecol Oncol. 2021 08; 162(2):368-374.
Score: 0.162
-
Matsuo K, Enserro DM, Wright JD, Roman LD, Powell MA, Miller DS, Nagel CI, Thaker PH, Mannel RS, Stuckey AR, Guntupalli SR, Sukumvanich P, Geller MA, Vargas R, Konecny GE, Warshal DP, Tewari KS, Spirtos NM, Pothuri B, Creasman WT, Mutch DG. Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol. Gynecol Oncol. 2025 Oct; 201:184-194.
Score: 0.054
-
Lampert EJ, Hansen JL, Tewari S, Yao M, Chambers LM, Vargas R, AlHilli MM. Higher incidence of venous thromboembolism associated with increasing lines of treatment in heavily treated ovarian cancer patients. Int J Gynecol Cancer. 2024 08 05; 34(8):1246-1252.
Score: 0.050
-
Morton M, Yao M, Chalif J, Lampert EJ, Chau D, Rose PG, Debernardo R, Michener CM, Vargas R, Chambers LM. Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian Cancer. Obstet Gynecol. 2023 09 01; 142(3):459-466.
Score: 0.047
-
Chambers LM, Esakov Rhoades EL, Bharti R, Braley C, Tewari S, Trestan L, Alali Z, Bayik D, Lathia JD, Sangwan N, Bazeley P, Joehlin-Price AS, Wang Z, Dutta S, Dwidar M, Hajjar A, Ahern PP, Claesen J, Rose P, Vargas R, Brown JM, Michener CM, Reizes O. Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer. Cancer Res. 2022 12 16; 82(24):4654-4669.
Score: 0.045